DA-033 20 Pill - white round, 8mm
Generic Name: aripiprazole
Pill with imprint DA-033 20 is White, Round and has been identified as Abilify MyCite 20 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd.
Abilify MyCite is used in the treatment of Bipolar Disorder; Depression; Schizophrenia and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Abilify MyCite 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DA-033 20
Abilify MyCite
- Generic Name
- aripiprazole
- Imprint
- DA-033 20
- Strength
- 20 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Atypical antipsychotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Otsuka Pharmaceutical Co., Ltd
- National Drug Code (NDC)
- 59148-0033
- Inactive Ingredients
-
corn starch,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
ferric oxide yellow,
ferric oxide red,
FD&C Blue No. 2,
aluminum oxide,
aluminum,
magnesium,
silicon,
silicon dioxide,
titanium,
triethyl citrate
Note: Inactive ingredients may vary.
More about Abilify MyCite (aripiprazole)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: atypical antipsychotics
- Breastfeeding
Patient resources
- Abilify MyCite Maintenance Kit oral with sensor drug information
- Abilify MyCite Starter Kit oral with sensor
- Abilify Mycite (Advanced Reading)
- Abilify MyCite
Other brands
Aristada, Abilify Asimtufii, Aristada Initio, Abilify Discmelt
Professional resources
Other brands
Aristada, Abilify Asimtufii, Aristada Initio
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
